Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 17Neoplasms 13Breast Neoplasms 12Neuroendocrine Tumors 8Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 7Neoplasm Metastasis 6Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Multiple Myeloma 4Rectal Neoplasms 3Pancreatic Neoplasms 3Mouth Neoplasms 3Lymphoma, Non-Hodgkin 3Glioma 3Esophageal Squamous Cell Carcinoma 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplastic Cells, Circulating 2Nasopharyngeal Carcinoma 2Multiple Pulmonary Nodules 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Liver Neoplasms 2Leukemia 2Hypoxia 2Hematologic Neoplasms 2Head and Neck Neoplasms 2

Interventions

Pancreaticoduodenectomy 2titanium silicide 1tislelizumab 1sonidegib 1paricalcitol 1mitazalimab 1lenvatinib 1ivosidenib 1irinotecan sucrosofate 1glucoraphanin 1devimistat 1Transurethral Resection of Prostate 1Tissue Banks 1Specimen Handling 1Saline Solution 1S 1 (combination) 1Ropivacaine 1Robotic Surgical Procedures 1Radiomics 1Positron Emission Tomography Computed Tomography 1Parturition 1PEGPH20 1Oxaliplatin 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Losartan 1Irinotecan 1Immunotherapy 1Hydroxychloroquine 1Glucose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Ductal Adenocarcinoma × Positron Emission Tomography Computed Tomography × Clear all
NCT03851237 2026-05-08

CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

Washington University School of Medicine

Phase 1 Completed
69 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡